NCT02544763 2022-09-28
A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
Clinical Trials
4 trialsNCT02544750 2022-07-14
An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Jazz Pharmaceuticals
Phase 3 Completed
NCT01601314 2018-01-17
MAGNA
Fundacion Clinic per a la Recerca Biomédica
Phase 3 Completed
NCT00790400 2017-02-17
EXIST-2
Novartis
Phase 3 Completed